Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-55
SponsorIcahn School of Medicine at Mount Sinai
About this trial
The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using wearable brain imaging, functional near-infrared spectroscopy (fNIRS), together with a brain-based 4-week text-messaging intervention. The investigators will examine how these interventions may influence inhibitory control and eating disorder symptoms in women with bulimia nervosa.
Eligibility criteria
Qualifiers
Female
Aged 18 to 55 years
Meet diagnostic criteria for bulimia nervosa (BN) or BN of low frequency and/or limited duration
Current body mass index greater than or equal to 18.5kg/m2 but under 40kg/m2
Disqualifiers
Ongoing medical treatment or planned/recent change in medical treatment, major medical condition, or psychiatric disorder that may interfere with study variables or participation
Current psychotherapy focused primarily on eating disorder symptoms
Pregnancy or planned pregnancy, or lactation during the study period
Allergy to ingredients in the shake
Trial design
Treatments tested in this trial
- Real fNIRS Neurofeedback
- Sham-Control fNIRS Neurofeedback
- SmartPhone Intervention
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov